Related Experiment Video
Updated: Jul 28, 2026

Surgical Models of Gastroesophageal Reflux with Mice
Published on: August 25, 2015
Crohn's Disease of the Esophagus, Duodenum, and Stomach
David M Schwartzberg1, Stephen Brandstetter1, Alexis L Grucela2
1Department of Colorectal Surgery, Digestive Disease Institute, Cleveland Clinic Foundation, Cleveland, Ohio.
Insights
Upper gastrointestinal Crohn's disease is often asymptomatic in adults but requires medical management for symptoms. Surgery is reserved for complications like obstruction, with strictureplasty and bypass being viable options.
Area of Science:
- Gastroenterology
- Inflammatory Bowel Disease
Background:
- Upper gastrointestinal Crohn's disease (UGCD) is an under-recognized manifestation of Crohn's disease.
- Prevalence is higher in pediatric populations, but most adults remain asymptomatic.
Purpose of the Study:
- To review the clinical presentation, management, and surgical outcomes of upper gastrointestinal Crohn's disease.
Main Methods:
- Literature review of symptomatic adult patients with UGCD.
- Analysis of medical and surgical treatment strategies and outcomes.
Main Results:
- Medical therapy (steroids, immunomodulators, biologics) is first-line for symptomatic UGCD.
- Surgery (strictureplasty, bypass) is indicated for obstruction, with comparable morbidity but different long-term complications.
- Rare fistulous disease may require complex surgical interventions.
Conclusions:
- UGCD requires careful diagnosis and management.
- Surgical options for obstructive UGCD are effective but carry specific risks.
- Fistulizing UGCD can necessitate highly morbid procedures.
Abstract:
Upper gastrointestinal Crohn's is an under-reported, under-recognized phenotype of Crohn's disease. Routine screening in the pediatric population has shown a higher prevalence compared with adults; however, most adult patients remain asymptomatic with respect to upper gastrointestinal Crohn's disease. For the patients who are symptomatic, medical treatment is the first line of management, except for cases of obstruction, perforation, or bleeding. Though most patients respond to medical therapy, mainly steroids, with the addition of immunomodulators and more recently biologics agents, surgical intervention is usually required only for obstructing gastroduodenal disease secondary to strictures. Strictureplasty and bypass are safe operations with comparable morbidity, although bypass has higher rates of dumping syndrome and marginal ulceration in the long term. Rare cases of gastroduodenal fistulous disease from active distal disease may involve the stomach or duodenum, and esophageal Crohn's disease can fistulize to surrounding structures in the mediastinum which may require the highly morbid esophagectomy.
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Other Disorders of Digestive System
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Esophageal Achalasia
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease III: Crohn's Disease

